Anhui Palo Alto Pharmaceuticals, Inc.
Clinical trials sponsored by Anhui Palo Alto Pharmaceuticals, Inc., explained in plain language.
-
New asthma drug candidate PA9159 passes first safety check in healthy volunteers
Disease control CompletedThis early-stage study tested a new asthma medication called PA9159, given as an inhaled aerosol, in 40 healthy adults in China. The main goal was to see if it is safe and how the body processes it. Researchers monitored side effects, vital signs, and lab tests after single and r…
Phase: PHASE1 • Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New nasal spray for allergies passes first safety check
Symptom relief CompletedThis early-stage trial tested the safety and tolerability of a new corticosteroid nasal spray called PA9159 in 36 healthy Chinese adults. Participants received either a single dose or seven daily doses of the spray, or a placebo. The goal was to find the maximum safe dose and see…
Phase: PHASE1 • Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC